- Home
- ETON vs DIBS Comparison
ETON vs DIBS Comparison
Compare ETON & DIBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- DIBS
- Stock Information
- Founded
- ETON 2017
- DIBS 2000
- Country
- ETON United States
- DIBS United States
- Employees
- ETON N/A
- DIBS N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- DIBS Catalog/Specialty Distribution
- Sector
- ETON Health Care
- DIBS Consumer Discretionary
- Exchange
- ETON Nasdaq
- DIBS Nasdaq
- Market Cap
- ETON 388.3M
- DIBS 88.1M
- IPO Year
- ETON 2018
- DIBS 2021
- Fundamental
- Price
- ETON $14.85
- DIBS $2.78
- Analyst Decision
- ETON Strong Buy
- DIBS Hold
- Analyst Count
- ETON 3
- DIBS 1
- Target Price
- ETON $29.67
- DIBS N/A
- AVG Volume (30 Days)
- ETON 621.3K
- DIBS 243.5K
- Earning Date
- ETON 08-07-2025
- DIBS 08-05-2025
- Dividend Yield
- ETON N/A
- DIBS N/A
- EPS Growth
- ETON N/A
- DIBS N/A
- EPS
- ETON N/A
- DIBS N/A
- Revenue
- ETON $48,327,000.00
- DIBS $88,740,000.00
- Revenue This Year
- ETON $103.21
- DIBS $3.02
- Revenue Next Year
- ETON $51.34
- DIBS $6.51
- P/E Ratio
- ETON N/A
- DIBS N/A
- Revenue Growth
- ETON 40.88
- DIBS 4.93
- 52 Week Low
- ETON $3.25
- DIBS $2.30
- 52 Week High
- ETON $21.48
- DIBS $5.00
- Technical
- Relative Strength Index (RSI)
- ETON 54.31
- DIBS 51.65
- Support Level
- ETON $13.78
- DIBS $2.67
- Resistance Level
- ETON $16.27
- DIBS $2.83
- Average True Range (ATR)
- ETON 0.83
- DIBS 0.19
- MACD
- ETON 0.32
- DIBS -0.01
- Stochastic Oscillator
- ETON 77.67
- DIBS 34.62
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The Company has a single reportable and operating segment that contains one reporting unit, which consists of the Company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.